Aurinia Pharmaceuticals (AUPH) Insider Trading & Ownership $8.16 +0.05 (+0.62%) Closing price 04:00 PM EasternExtended Trading$8.28 +0.13 (+1.53%) As of 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aurinia Pharmaceuticals (NASDAQ:AUPH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$2.89 M Get AUPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Aurinia Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AUPH Insider Buying and Selling by Quarter Remove Ads Aurinia Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/7/2025Greg KeenanInsiderSell8,305$8.23$68,350.15 3/3/2025Greg KeenanInsiderSell12,239$8.00$97,912.00 3/3/2025Joseph M MillerCFOSell61,859$8.00$494,872.00 3/3/2025Matthew Maxwell DonleyCOOSell65,902$8.00$527,216.00 3/3/2025Peter GreenleafCEOSell195,593$8.00$1,564,744.00 11/11/2024Jeffrey Allen BaileyDirectorSell4,557$8.43$38,415.51 8/6/2024Scott Michael HabigInsiderSell18,249$5.31$96,902.19 (Data available from 1/1/2013 forward) AUPH Insider Trading Activity - Frequently Asked Questions Who is on Aurinia Pharmaceuticals's Insider Roster? The list of insiders at Aurinia Pharmaceuticals includes David R.W. Jayne, George M Milne Jr, Greg Keenan, Jeffrey Allen Bailey, Joseph M Miller, Joseph P Hagan, Matthew Maxwell Donley, Peter Greenleaf, Scott Michael Habig, and Stephen P Robertson. Learn more on insiders at AUPH. What percentage of Aurinia Pharmaceuticals stock is owned by insiders? 4.30% of Aurinia Pharmaceuticals stock is owned by insiders. Learn more on AUPH's insider holdings. Which Aurinia Pharmaceuticals insiders have been selling company stock? The following insiders have sold AUPH shares in the last 24 months: David R.W. Jayne ($98,333.58), Greg Keenan ($166,262.15), Jeffrey Allen Bailey ($38,415.51), Joseph M Miller ($494,872.00), Joseph P Hagan ($2,877.76), Matthew Maxwell Donley ($527,216.00), Peter Greenleaf ($1,564,744.00), and Scott Michael Habig ($96,902.19). How much insider selling is happening at Aurinia Pharmaceuticals? Insiders have sold a total of 375,709 Aurinia Pharmaceuticals shares in the last 24 months for a total of $2,989,623.19 sold. Aurinia Pharmaceuticals Key ExecutivesMr. Peter S. Greenleaf M.B.A. (Age 54)President, CEO & Director Compensation: $1.57MMr. Joseph M. Miller CPA (Age 50)Chief Financial Officer Compensation: $883.19k1 recent tradesMr. Matthew Maxwell Donley M.B.A. (Age 55)Executive Vice President of Operations & Strategy Compensation: $901.84k1 recent tradesMr. Stephen P. Robertson (Age 42)Executive VP, General Counsel, Corporate Secretary & Chief Compliance Officer Compensation: $836.38kMs. Andrea Levin ChristopherHead of the Corporate Communications & Investor RelationsMr. Michael R. Martin (Age 52)Chief Business Officer Compensation: $350.57kMs. Sue EvansSenior Vice President of Global Regulatory AffairsMr. Scott Habig (Age 64)Chief Commercial Officer Dr. Gregory F. Keenan M.D.Chief Medical OfficerDr. Ann M. Daus Ph.D.Senior Vice President of Quality More Insider Trading Tools from MarketBeat Related Companies PTCT Insider Selling OGN Insider Selling ACLX Insider Selling ADMA Insider Selling ZLAB Insider Selling SWTX Insider Selling RNA Insider Selling RARE Insider Selling IMVT Insider Selling PTGX Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles SentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are Buying This page (NASDAQ:AUPH) was last updated on 3/14/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredOur #1 Defense Stock for MarchChina just deepened its military alliance with America's enemies in the Middle East... By conducting joint ...Behind the Markets | SponsoredElon’s desperate gambleWarning: "DOGE Collapse" Imminent After months of cost-cutting, controversy, and media buzz, DOGE is on the...Altimetry | SponsoredIs 2025 really the best time to get rich in American history?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurinia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurinia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
